: : : 2007-04-09 to 2007-04-15
Permax: FDA Public Health Advisory (Pergolide)
April 9, 2007 15:16
FDA Permax: Companies that manufacture and distribute pergolide have agreed to withdraw this drug from the market due to the potential for heart valve damage. Two new studies demonstrate that patients with Parkinson's disease who were treated with pergolide... (Read Article)
Permax: FDA Recalls Parkinson's Drug that Causes Heart Valve Damage
April 10, 2007 15:15
Isn't it bad enough to have to deal with Parkinson's disease and then have a life threatening side effect on top of one medical hardship?About 12,200 to 25,000 currently taking Permax for Parkinson's disease will have to find a new prescription drug. Permax... (Read Article)
Link between Permax and Leaky Heart Valve Problems
April 11, 2007 15:11
Health Canada (similar to the U.S. version of the FDA) is informing Canadians that Permax has been withdrawn from the U.S. market because of concerns with cardiac valvulopathy, a condition involving inflammation or stiffening of the heart valves. Permax (a... (Read Article)